Company
Eos SENOLYTIX
Improving healthspan, increasing lifespan
Also known as Eos SENOLYTIX, Inc.
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
We are a longevity biotechnology company developing novel gerotherapeutics that target the fundamental mechanisms of aging.
Funding snapshot
- Total raised
- $750KSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $750K2026-06-04
Funding rounds
- Round, 2026
- $750K2026-06-04, SEC form D sold, 2 investors
Products
- Other
- PTC-2105
- Other
- PTC-2107
Loading relationship preview